Nitrome Biosciences

Nitrome Biosciences

Developing drugs against a newly identified class of enzymes. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD294m (Public information from Nov 2021)
San Francisco California (HQ)
Authorizing premium user...